{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:11Z","timestamp":1792791491796,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013276","name":"Interreg","doi-asserted-by":"publisher","award":["EMR116"],"award-info":[{"award-number":["EMR116"]}],"id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013276","name":"Interreg","doi-asserted-by":"publisher","award":["2014-055"],"award-info":[{"award-number":["2014-055"]}],"id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016062","name":"Metakids Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["PBSW.0R15-09"],"award-info":[{"award-number":["PBSW.0R15-09"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ymthe.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:29:16Z","timestamp":1752766156000},"page":"5061-5072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: First phase 1\/2 human clinical study"],"prefix":"10.1016","volume":"33","author":[{"given":"Florence H.J.","family":"van Tienen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke G.J.","family":"Hoeijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan","family":"van der Leij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Timmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangzheng","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne P.M.","family":"Kortekaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Roelofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge M.","family":"Westra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Meij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambert A.C.M.","family":"Wijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irenaeus F.M.","family":"de Coo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert J.M.","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.07.005_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s13311-018-00674-4","article-title":"Diagnosis and Treatment of Mitochondrial Myopathies","volume":"15","author":"Ahmed","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2025.07.005_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.07.005_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/301959","article-title":"Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population","volume":"63","author":"Majamaa","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.07.005_bib4","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archneur.63.12.1701","article-title":"Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation","volume":"63","author":"Jeppesen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymthe.2025.07.005_bib5","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/brain\/awh515","article-title":"Spectrum of myopathic findings in 50 patients with the 3243A>G mutation in mitochondrial DNA","volume":"128","author":"K\u00e4rpp\u00e4","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ymthe.2025.07.005_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2024-000825","article-title":"Neurological manifestations in adult patients with the m.3243A>G variant in mitochondrial DNA","volume":"6","author":"Majamaa","year":"2024","journal-title":"BMJ Neurol. Open"},{"key":"10.1016\/j.ymthe.2025.07.005_bib7","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/jimd.12546","article-title":"Identifying trajectories of fatigue in patients with primary mitochondrial disease due to the m.3243A > G variant","volume":"45","author":"Klein","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2025.07.005_bib8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.15252\/emmm.201505079","article-title":"Mitochondrial disease in adults: what's old and what's new?","volume":"7","author":"Chinnery","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.07.005_bib9","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200229","article-title":"Characterization of Fatigue in Primary Mitochondrial Myopathies","volume":"14","author":"Karaa","year":"2024","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.ymthe.2025.07.005_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.1082254","article-title":"Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts","volume":"301","author":"Sampaolesi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.07.005_bib11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature05282","article-title":"Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs","volume":"444","author":"Sampaolesi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.005_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ncb1542","article-title":"Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells","volume":"9","author":"Dellavalle","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.07.005_bib13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15252\/emmm.201505636","article-title":"Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy","volume":"7","author":"Cossu","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.07.005_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s13287-019-1510-8","article-title":"Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy","volume":"10","author":"van Tienen","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2025.07.005_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28967-w","article-title":"Fate of mesoangioblasts in a vaginal birth injury model: influence of the route of administration","volume":"8","author":"Mori da Cunha","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.07.005_bib16","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1111\/j.1600-0838.2009.00947.x","article-title":"A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise","volume":"20","author":"Paulsen","year":"2010","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.ymthe.2025.07.005_bib17","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1152\/japplphysiol.00148.2009","article-title":"Gross ultrastructural changes and necrotic fiber segments in elbow flexor muscles after maximal voluntary eccentric action in humans","volume":"107","author":"Lauritzen","year":"2009","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ymthe.2025.07.005_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3727\/096368909X","article-title":"Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase","volume":"19","author":"Boddington","year":"2010","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ymthe.2025.07.005_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/humupd\/dms008","article-title":"PGD and heteroplasmic mitochondrial DNA point mutations: a systematic review estimating the chance of healthy offspring","volume":"18","author":"Hellebrekers","year":"2012","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.ymthe.2025.07.005_bib21","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1093\/hmg\/ddt327","article-title":"Mitochondrial DNA deletions in muscle satellite cells: implications for therapies","volume":"22","author":"Spendiff","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1042\/BST20190238","article-title":"Evolving mtDNA populations within cells","volume":"47","author":"Johnston","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymthe.2025.07.005_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/OPTH.S234858","article-title":"Immediate Reactions to Fluorescein and Indocyanine Green in Retinal Angiography: Review of Literature and Proposal for Patient's Evaluation","volume":"14","author":"Meira","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ymthe.2025.07.005_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/boc.201200022","article-title":"Sdf-1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells","volume":"104","author":"Brzoska","year":"2012","journal-title":"Biol. Cell"},{"key":"10.1016\/j.ymthe.2025.07.005_bib25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3727\/000000007783465064","article-title":"Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients","volume":"16","author":"Torrente","year":"2007","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ymthe.2025.07.005_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200512085","article-title":"Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability","volume":"174","author":"Galvez","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.07.005_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12714","article-title":"Aging affects the in vivo regenerative potential of human mesoangioblasts","volume":"17","author":"Rotini","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.ymthe.2025.07.005_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029760","article-title":"Eccentric exercise facilitates mesenchymal stem cell appearance in skeletal muscle","volume":"7","author":"Valero","year":"2012","journal-title":"PLoS One"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625005416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625005416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:41Z","timestamp":1792788401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625005416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1525001625005416"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.17.24319434","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: First phase 1\/2 human clinical study","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}